Sun Pharma on Wednesday said it has entered into an exclusive patent licensing agreement with Danish-drugmaker Lundbeck to market and distribute its own version of antidepressant medication Vortioxetine in India under the brand name Vortidiftm.
UnitedHealth Group said on Tuesday it would purchase LHC Group for about $5.4 billion in cash, as the largest U.S. health insurer expands its home health services.
Strides Pharma on Tuesday said its founder-promoter Arun Kumar will be assuming executive role as executive chairperson and managing Director effective April 7.
India’s free trade pact with the UAE eliminated tariffs on finished pharmaceutical goods but restricted access to the gulf nation’s energy resources.
Alembic Pharmaceuticals on Tuesday said it has acquired the balance 40% stake in Aleor Dermaceuticals from its JV Partner Orbicular Pharmaceutical Technologies to strengthen its skin-related built-up and marketing footprint.
Drug maker Aurobindo Pharma on Monday said it has acquired the domestic formulations business of Veritaz for Rs 171 crore on debt free and cash-free basis.
Tata Capital on Monday declared that a Rs 955 crore fundraise by a private equity arm for investing in healthcare companies. The Tata Capital Healthcare Fund II attained a final closure of its fund with investor commitments of Rs 955 crore or USD
The Telangana government on Sunday said US-based complex generic and specialty drugs player, Slayback Pharma, will be capitalizing $ 20 million towards expansion of its operations in Hyderabad over the next three years.
The Serum Institute has applied to the Drugs Controller General of India seeking emergency use authorisation for its recombinant BCG (rBCG) vaccine for the prevention.
Prices of around 800 essential medicines comprising antibiotics, anti-infective and painkillers are set to rise from April, as the government has allowed an increase of over 10 per cent for the scheduled drugs.
, CDSCO.jpg)
